Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pathologic Complete Response × Folfox protocol × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 22 Colonic Neoplasms 7 Rectal Neoplasms 6 Neoplasm Metastasis 5 Cholangiocarcinoma 5 Stomach Neoplasms 4 Carcinoma, Hepatocellular 4 Biliary Tract Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Neoplasms 2 Gallbladder Neoplasms 2 Cirrhosis, Familial, with Pulmonary Hypertension 2 Adenocarcinoma Of Esophagus 2 Solid Tumors 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Lung Neoplasms 1 Locally Advanced Rectal Cancer 1 Locally Advanced Pancreatic Carcinoma(LAPC) 1 Locally Advanced Colorectal Carcinoma 1 Liver Neoplasms 1 Gastrointestinal Neoplasms 1 Gastroesophageal Junction Adenocarcinoma 1 Gastroesophageal Adenocarcinoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Esophageal Neoplasms 1 Disease Progression 1 Colorectal Cancer With Liver Metastasis 1 Colorectal Cancer Metastatic 1

Interventions

Carboplatin 4 pembrolizumab 3 Paclitaxel 3 Capecitabine 3 Azacitidine 3 venetoclax 2 pertuzumab 2 olaparib 2 durvalumab 2 Trastuzumab 2 Standard of Care 2 Oxaliplatin 2 Observation 2 Irinotecan 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Chemoradiotherapy 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 taxane 1 talazoparib 1 tagraxofusp 1 sarilumab 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡